This phase IV trial studies how well serial magnetic resonance imaging (MRI) after radiation therapy works in predicting radiation-induced changes in the normal tissue of patients with oral cavity or skull base tumors. Performing MRIs after radiation therapy for patients with oral cavity or skull base tumors may help to predict osteoradionecrosis (a change in non-cancerous tissue).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Radiotherapy-attributable imaging for normal tissue injury
Timeframe: Up to 1 year
Dose-response correlation between imaging biomarkers
Timeframe: Up to 1 year
Dose-response correlation between subsequent radiation-induced effects
Timeframe: Up to 1 year